Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...
IIT Kanpur scientists have unlocked the mystery behind the C5aR2 immune receptor's unique function. Using advanced cryo-EM, ...
Kaufbeuren will be home to the system’s radar site, while the actual interceptor launchers for that battery are planned for ...
Newsable Asianet News on MSN
IIT Kanpur researchers solve mystery of immune receptor C5aR2's function
IIT Kanpur researchers, led by Professor Arun K Shukla, used cryo-EM to uncover the molecular basis of the atypical immune receptor C5aR2. They revealed its unique structure and developed a molecule ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the European Medicines Agency's (EMA) ...
Intellectual Property / Electric Propulsion Technology. New U.S. patent filing advances E-Motion™ electric outboard ...
A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...
Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing ...
Google has showcased Android 17's foldable gaming mode, turning foldables into handheld consoles with a customizable virtual ...
A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results